Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1281P is a member of the large family of U6 small nuclear RNA (snRNA) pseudogenes in the human genome[7]. U6 snRNA itself is an essential and highly conserved component of the spliceosome, the complex that catalyzes pre-mRNA splicing in the nucleus[1][3]. However, RNU6-1281P does not encode a functional snRNA; rather, it is classified as a pseudogene, meaning it is a genomic DNA sequence similar to the functional U6 snRNA genes but is nonfunctional, likely due to accumulated mutations or truncations that prevent proper expression or function[4][5][7]. Many U6-related pseudogenes have been identified in the human genome, reflecting the evolutionary importance and high copy number of the U6 snRNA gene family[3][5]. RNU6-1281P is assigned the official gene symbol RNU6-1281P by the HGNC (HGNC: 48244) and NCBI Gene (ID: 106480125)[7]. It has no recognized protein product and is not involved in any known disease process or therapeutic context.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1281, pseudogene (RNU6-1281P).